Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Sepiapterin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sephience Gets EU OK for PKU Drug Sepiapterin
    Sephience Gets EU OK for PKU Drug Sepiapterin

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sephience-sepiapterin-granted-marketing-authorization-by-the-european-commission-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-302490040.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share
    Sephience (Sepiapterin) Approved by European Commission for PKU
    Sephience (Sepiapterin) Approved by European Commission for PKU

    23 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sephience-sepiapterin-granted-marketing-authorization-by-the-european-commission-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-302487940.html

    PR NEWSWIRE
    23 Jun 2025
    Share Share
    PTC Therapeutics Gets Positive CHMP Opinion for Sephience for PKU
    PTC Therapeutics Gets Positive CHMP Opinion for Sephience for PKU

    25 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-receives-positive-chmp-opinion-for-sephience-sepiapterin-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-302438377.html

    PR NEWSWIRE
    25 Apr 2025
    Share Share
    PTC Therapeutics' NDA for Sepiapterin Accepted for Phenylketonuria
    PTC Therapeutics' NDA for Sepiapterin Accepted for Phenylketonuria

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-fda-acceptance-for-filing-of-nda-for-sepiapterin-for-the-treatment-of-pediatric-and-adult-phenylketonuria-patients-302263975.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share
    PTC Therapeutics Reports Q2 2024 Results And Corporate Update
    PTC Therapeutics Reports Q2 2024 Results And Corporate Update

    08 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-corporate-update-and-reports-second-quarter-2024-financial-results-302218200.html

    PR NEWSWIRE
    08 Aug 2024
    Share Share
    PTC Therapeutics Announces Validation of Sepiapterin European MAA
    PTC Therapeutics Announces Validation of Sepiapterin European MAA

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-validation-of-sepiapterin-european-maa-302156304.html

    PR NEWSWIRE
    28 May 2024
    Share Share